Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 48 of 95, showing 5 Applications out of 471 total, starting on record 236, ending on 240

# Protocol No Study Title Investigator(s) & Site(s)

236.

ECCT/20/04/03   518 & 525-SHAN6™
    Study Title: Safety and Immunogenicity Study of Full Schedule (3-Dose SHAN6™) or SHAN6™- SHAN 5®- SHAN6™ Versus the Licensed Vaccine SHAN 5® With bOPV and IPV When Administered Per National Immunization Schedule in Healthy Kenyan Infants.    Phase III, multi-center, randomized, active-controlled, open-label, three-arm, study in 690 infants who will receive a 3-dose primary series at 6, 10 and 14 weeks of age, of either 3-dose SHAN6™ or SHAN6™ – SHAN 5® + bOPV – SHAN6™ or SHAN 5® + bOPV – SHAN 5® + bOPV – SHAN 5® + bOPV + IPV, and a booster dose of either SHAN6™ or SHAN 5® + bOPV at 18 months of age   
Principal Investigator(s)
1. Bernhards Ogutu
2. Godfrey Allan Otieno
3. Videlis Nduba
4. Lucy Chepkurui Koech
5. samuel Gurrion Ouma
6. Janet Oyieko
Site(s) in Kenya
1. Ahero Clinical Trials Unit (Kisumu county)
2. KEMRI, Centre for Respiratory Diseases Research (CRDR) (Nairobi City county)
3. KEMRI Kondele Children’s Hospital (Kisumu county)
4. KEMRI / Walter Reed Project, Clinical Research Centre, Kericho (Kericho county)
5. KEMRI CGHR, CLINICAL RESEARCH CENTRE (Kisumu county)
6. KEMRI Centre forClinical Research(CCR)_Butere County Hospital (Kakamega county)
7. CRDR_Siaya Annex(Back-up site) (Siaya county)
 
View

237.

ECCT/15/06/02   ZINC in Sickle cell study
    The effects of Zinc supplementation in children with sickle cell disease in Western Kenya: a pilot study.   
Principal Investigator(s)
1. Lucas Otieno Tina
Site(s) in Kenya
Health Facilities in Western Kenya
 
View

238.

ECCT/21/06/11   Pulse oximeter use in labour
    The use of Fetal Pulse Oximetry in determining fetal wellbeing during labour: A non-randomized clinical trial       
Principal Investigator(s)
1. Felix Mwembi Oindi
Site(s) in Kenya
Aga Khan University hospital
 
View

239.

ECCT/13/05/01  
    Use of the Shang Ring device in all four childhood age groups in the African population   
Principal Investigator(s)
1. Quentin David Awori
Site(s) in Kenya
Homa Bay District Hospital
 
View

240.

ECCT/13/04/08  
    Switching At Low HIV-1 RNA Into Fixed Dose Combinations   SALIF   Protocol Number: TMC278IFD3002 Amendment INT-1   
Principal Investigator(s)
1. Edwin Onyango WERE
2. Milton Tony OMONDI
3. Gina OUATTARA
4. Gaudensia Nzembi MUTUA
5. Reena SHAH
Site(s) in Kenya
1. Aga Khan University Hospital (Nairobi City county)
2. KEMRI/Walter-Reed Project Kombewa (Kisumu county)
3. Partners in Prevention (Uasin Gishu county)
4. Kenya AIDS Vaccine Initiative - KNH (Nairobi City county)
5. Kenya AIDS Vaccine Initiative - Kangemi (Nairobi City county)
 
View